Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic and predictive impact of gene expression in node-positive early breast cancer patients receiving dose-dense versus standard-dose adjuvant chemotherapy.
Reinisch M, Bruzas S, Gluz O, Ataseven B, Schmid P, Cortés J, Blohmer JU, Shenoy S, Dyson MH, Dittmer-Grabowski C, Chiari O, Harrach H, Gebauer D, Traut A, Kuemmel S. Reinisch M, et al. Among authors: gebauer d. Mol Oncol. 2023 Jun;17(6):1060-1075. doi: 10.1002/1878-0261.13435. Epub 2023 Apr 24. Mol Oncol. 2023. PMID: 37057719 Free PMC article.
Gene signatures in patients with early breast cancer and relapse despite pathologic complete response.
Bruzas S, Gluz O, Harbeck N, Schmid P, Cortés J, Blohmer J, Seiberling C, Chiari O, Harrach H, Ataseven B, Shenoy S, Dyson MH, Traut E, Theuerkauf I, Gebauer D, Kuemmel S, Reinisch M. Bruzas S, et al. Among authors: gebauer d. NPJ Breast Cancer. 2022 Mar 29;8(1):42. doi: 10.1038/s41523-022-00403-3. NPJ Breast Cancer. 2022. PMID: 35351903 Free PMC article.
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial.
Gluz O, Kolberg-Liedtke C, Prat A, Christgen M, Gebauer D, Kates R, Paré L, Grischke EM, Forstbauer H, Braun M, Warm M, Hackmann J, Uleer C, Aktas B, Schumacher C, Kuemmel S, Wuerstlein R, Pelz E, Nitz U, Kreipe HH, Harbeck N. Gluz O, et al. Among authors: gebauer d. Int J Cancer. 2020 Jan 1;146(1):262-271. doi: 10.1002/ijc.32488. Epub 2019 Jun 19. Int J Cancer. 2020. PMID: 31162838 Clinical Trial.
De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial.
Gluz O, Nitz U, Kolberg-Liedtke C, Prat A, Christgen M, Kuemmel S, Mohammadian MP, Gebauer D, Kates R, Paré L, Grischke EM, Forstbauer H, Braun M, Warm M, Hackmann J, Uleer C, Aktas B, Schumacher C, Wuerstlein R, Graeser M, Pelz E, Jóźwiak K, Zu Eulenburg C, Kreipe HH, Harbeck N; ADAPT TN investigators. Gluz O, et al. Among authors: gebauer d. Clin Cancer Res. 2022 Nov 14;28(22):4995-5003. doi: 10.1158/1078-0432.CCR-22-0482. Clin Cancer Res. 2022. PMID: 35797219
Simplified Pain Management Including Fentanyl TTS in PACU Patients With Hip Fracture Surgery to Improve Patients' Well-Being: A Double-Blind Randomized Trial.
Labmayr V, Rief M, Reinbacher P, Gebauer D, Smigaj J, Sandner-Kiesling A, Papamargaritis V, Michaeli K, Bornemann-Cimenti H, Schittek GA. Labmayr V, et al. Among authors: gebauer d. J Perianesth Nurs. 2024 Jun;39(3):461-467. doi: 10.1016/j.jopan.2023.10.004. Epub 2023 Dec 11. J Perianesth Nurs. 2024. PMID: 38085188 Free article. Clinical Trial.
136 results